FDA, DEA Urge Fix for Shortage of Stimulants, a Drug Class Used to Treat Narcolepsy
The US Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) issued a joint statement updating the public on ongoing actions being taken to resolve the shortage of prescription stimulants, a class of drugs often used to treat narcolepsy. The agencies acknowledge in the statement that the lack of availability of certain medications…